Your browser doesn't support javascript.
loading
Roles of TGF-ß signals in tumor microenvironment via regulation of the formation and plasticity of vascular system.
Watabe, Tetsuro; Takahashi, Kazuki; Pietras, Kristian; Yoshimatsu, Yasuhiro.
Affiliation
  • Watabe T; Department of Biochemistry, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan. Electronic address: t-watabe.bch@tmd.ac.jp.
  • Takahashi K; Department of Biochemistry, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan; Institute of Industrial Science, The University of Tokyo, Tokyo, Japan.
  • Pietras K; Department of Laboratory Medicine, Division of Translational Cancer Research, Lund University Cancer Centre, Medicon Village, Lund University, 223 81 Lund, Sweden.
  • Yoshimatsu Y; Division of Pharmacology, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Japan.
Semin Cancer Biol ; 92: 130-138, 2023 07.
Article in En | MEDLINE | ID: mdl-37068553
ABSTRACT
Tumor cells evolve in tumor microenvironment composed of multiple cell types. Among these, endothelial cells (ECs) are the major players in tumor angiogenesis, which is a driver of tumor progression and metastasis. Increasing evidence suggests that ECs also contribute to tumor progression and metastasis as they modify their phenotypes to differentiate into mesenchymal cells through a process known as endothelial-mesenchymal transition (EndoMT). This plasticity of ECs is mediated by various cytokines, including transforming growth factor-ß (TGF-ß), and modulated by other stimuli depending on the cellular contexts. Recent lines of evidence have shown that EndoMT is involved in various steps of tumor progression, including tumor angiogenesis, intravasation and extravasation of cancer cells, formation of cancer-associated fibroblasts, and cancer therapy resistance. In this review, we summarize current updates on EndoMT, highlight the roles of EndoMT in tumor progression and metastasis, and underline targeting EndoMT as a potential therapeutic strategy.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Transforming Growth Factor beta / Endothelial Cells Limits: Humans Language: En Year: 2023 Type: Article

Full text: 1 Database: MEDLINE Main subject: Transforming Growth Factor beta / Endothelial Cells Limits: Humans Language: En Year: 2023 Type: Article